Follow the BioPharma Credit PLC share price and the full directors' dealings record of the company, a listed issuer based in United Kingdom. Shares trade on the UK market, under the authority of RNS (LSE). Market capitalisation: €1.1bn. The latest transaction was reported on 4 June 2026 (Purchase). Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
BioPharma Credit PLC 是一家专注于为生物制药公司提供融资的投资公司。其目标是提供资金以支持新疗法和药物的开发。